Alnylam Pharmaceuticals | 营业利润

股票价格

332.43

每天变化

1.19 0.36%

每月一次

-21.32%

每年

20.36%

Q1 预测

327.65

金融业

USD

USD 4.85B

现金及等价物

USD 1.49B

USD 200.15M

USD 3.95B

USD 1.56B

USD 1.3B

USD -29.96M

USD 381.79M

2.23K

EPS每股收益

USD 2.9

股本和储备

USD 233.89M

USD 1.05B

债务利息支出

USD 44.4M

USD 27.49M

USD 1.04B

USD 43.23B

USD 251.08M

USD 881.04M

USD -29.96M

普通股股本

USD 131.79M

538.03

USD 238.97M

USD 1.25B

销售和管理费用

USD 262.59M

USD 75.38M

贸易债权人

USD 117.59M

应收帐款人

USD 964.77M

	营业利润	更改		日
Acadia Pharmaceuticals	USD 35.76M		3.38M	2025-09
Agios Pharmaceuticals	USD -116.87M		10.19M	2025-09
Alnylam Pharmaceuticals	USD -29.96M		13.76M	2025-09
Amgen	USD 3.96B		464M	2025-12
Arrowhead Research	USD 40.81M		3.3M	2025-12
BioMarin Pharmaceutical	USD -31.69M		308.58M	2025-09
Incyte	USD 431.31M		120.49M	2025-09
Ionis Pharmaceuticals	USD -160.18M		300.02M	2025-09
Moderna	USD -260M		647M	2025-09
Neurocrine Biosciences	USD 239.3M		93.7M	2025-09
Novartis	USD 4.58B		879M	2025-09
PTC Therapeutics	USD 3.49M		38.35M	2025-09
Regeneron Pharmaceuticals	USD 898.6M		211.3M	2025-12
Sanofi	EUR 1.5B		2.29B	2025-12
Sarepta Therapeutics	USD -62.88M		178.46M	2025-09
Takeda	JPY 168.82B		479.89B	2025-12
Tectonic Therapeutic	USD -21.89M		440K	2025-09
Ultragenyx Pharmaceutical	USD -170.89M		22.68M	2025-09
Vertex Pharmaceuticals	USD 1.24B		84.6M	2025-09
Xencor	USD -47.52M		14.35M	2025-09

Alnylam Pharmaceuticals 营业利润 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.